Overcoming BTK Inhibitor Resistance in NHL

October 19, 2018
Julie M. Vose, MD, MBA

Julie M. Vose, MD, MBA, discusses resistance to BTK inhibitors in patients with non-Hodgkin lymphoma.

Julie M. Vose, MD, MBA, professor, internal medicine, chief, Division of Oncology & Hematology, University of Nebraska Medical Center, discusses resistance to BTK inhibitors in patients with non-Hodgkin lymphoma.